Full Text View
Tabular View
No Study Results Posted
Related Studies
Dichloroacetate Kinetics, Metabolism and Toxicology
This study has been completed.
Study NCT00015015   Information provided by National Institute of Environmental Health Sciences (NIEHS)
First Received: April 17, 2001   Last Updated: September 1, 2006   History of Changes

April 17, 2001
September 1, 2006
December 1994
 
 
 
Complete list of historical versions of study NCT00015015 on ClinicalTrials.gov Archive Site
 
 
 
Dichloroacetate Kinetics, Metabolism and Toxicology
 

Dichloroacetate (DCA) is a product of water chlorination and a metabolite of certain industrial solvents, thus making it a chemical of environmental concern. However, DCA is also used as an investigational drug for treating various diseases of adults and children, at doses far greater than those to which humans are normally exposed in the environment. Our research involves how DCA is metabolized by healthy adults and by children with a fatal genetic disease, congenital lactic acidosis (CLA) who are treated with DCA.

 
 
Observational
Screening, Longitudinal, Defined Population, Prospective Study
Lactic Acidosis
Drug: Dichloroacetate
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
100
October 2002
 

Children with congenital lactic acidosis Healthy adult volunteers

Both
3 Months to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00015015
 
7355-CP-001
National Institute of Environmental Health Sciences (NIEHS)
 
 
National Institute of Environmental Health Sciences (NIEHS)
September 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP